Palantir issued guidance for second-quarter revenue of $934 million to $938 million -- the midpoint of that would be a 38% increase from Q2 2024. Its full-year guidance is now in a range from $3.89 ...

About This EventAtriCure (Nasdaq: ATRC), visits the Nasdaq MarketSite in Times Square. AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions.In honor of the ...